Month: April 2013
Obagi Medical gets higher offer from Merz Pharma
(Reuters) – Neurological and dermatology drugs maker Merz Pharma Group offered to buy cosmetic products maker Obagi Medical Products Inc for $383.5 million, topping a bid by Canada’s Valeant Pharmaceuticals International Inc . Merz’s $22 per share bid represents a premium of 11 percent to Valeant’s offer of $19.75. Obagi shares were trading above Merz’s offer price at $22.90 in premarket trade, suggesting that some investors expect a bidding war. …
New Research By The Hartford And MIT AgeLab Shows Positive Effects Of Exercise On Mature Drivers
In the UK, a DIY approach to mental health help
Philippines: Navy Ships, Personnel Deliver Cargo for Major Exercise …
A Simple Exercise on Working with Natural Light in Portraits
Exercise Balls Bounce Into Garland School | NBC 5 Dallas-Fort Worth
6 Tips to Avoid Dangerous Weight Loss and Health Fraud Scams
Unfortunately, springtime is prime time for the advertising of bogus weight loss products and other get-in-shape dietary supplement rip-offs. According to the Food and Drug Administration (FDA), “a health product is fraudulent if it is deceptively …
See all stories on this topic »
alternative medicine to femara – Kumköy Beach Resort Hotel & SPA
My canadian pharmacy online – alternative medicine to femara… Cheap Prices, Fast Delivery By Airmail — alternative medicine to femara. Learn where to buy …
kumkoybeachresort.sunishotel.com/pharmacy/?szbs…
Complimentary and Alternative Medicine – Student Doctor Network Forums
CAM student and practitioner discussion forums – co-hosted with NARF.
forums.studentdoctor.net/forumdisplay.php?f=960
Questions in China on how H7N9 flu strain killed 2
Statin side effects can often be overcome: study
By Genevra Pittman NEW YORK (Reuters Health) – Most people who stop taking cholesterol-lowering statins – because of side effects or for another reason – are able to restart the same drug or a similar one without lasting problems, a new study suggests. That’s important because for people who need statins, quitting them for good increases the chance of serious heart problems, researchers said, so doctors and patients should think carefully before letting milder reactions lead them to give up on the drugs altogether. …